Introduction
Our laboratory has shown that adenoviral-mediated interferon a (Ad-IFNa) is highly cytotoxic to tumor cells resistant to the IFNa protein. Ad-IFNa also produces a strong bystander effect in cancer cells, which in turn can be seen in conditioned medium (CM) from either normal and cancer cells after Ad-IFNa infection, but is not cytotoxic to normal urothelial cells. [1] [2] [3] [4] In addition, intravesical Ad-IFNa is presently being used in a Phase l trial for BCG resistant superficial bladder cancer.
To better understand the possible mechanisms by which normal urothelial cells are spared from the cytotoxic effects observed in cancer cells, we decided to investigate the role of autophagy in protecting the normal cells. Indeed, we found that the differences in the degree and stages of autophagy produced in normal versus cancer cells were related to the direct effect of Ad-IFNa transfection and expression, whereas no autophagy was observed in either cell type as a result of the bystander factors. These results in turn may provide at least one mechanism to allow cell survival for normal urothelial cells after Ad-IFNa treatment.
Materials and methods

Cell lines
The bladder cancer cell lines, UM-UC9 bladder and KU7 cells were grown using minimal essential medium in 10% fetal bovine serum, supplemented with penicillin and streptomycin, and incubated at 37 1C in 5% CO 2 and 95% air. The normal urothelial cell line (TERT-NHUC), provided by Dr Margaret Knowles, was grown in K-SFM medium containing BPE and EGF and cholera toxins as supplements. 4 Cells were infected with a 100 MOI of Ad-IFNa or Ad-b-gal, which were both obtained from the Schering-Plough Research Institute (Kenilworth, NJ). The infection procedure was done as described earlier. 2 The cells were exposed to the adenoviral vector for 3 h in medium without serum. The virus was then removed and complete control medium was added. Transfection frequency was checked by immunostaining to assure that the different experiments were comparable. The autophagy inhibitor 3-methyladenine (3-MA) was purchased from SigmaAldrich (St Louis, MO). After Ad-IFNa infection, the tumor cells or normal cells were cultured with growth medium containing or not containing 2-5 mM 3-MA.
Western blotting
Western blotting was performed to measure light chain 3 (LC3)-II. The cultured cells were lysed in cold lysis buffer (1% Triton X-100, 1 mM EDTA, 150 mM NaCl, 50 mM Tris-HCl, 0.2 mM Na 2 VO 4 , and 10 mg ml À1 each of leupeptin, phenylmethylsulfonyl fluoride and apotine (Roche Molecular Biochemical, Indianapolis, IN)) and the soluble proteins isolated as described earlier. Protein concentrations were estimated by the Pierce protein assay (Thermo, Rockford, IL). 50 mg of each protein sample was separated by 4-20% SDS-PAGE and transferred to low fluorescence PVDF membrane (Thermo). The membrane was then blotted by using a rabbit polyclonal anti-microtubule-associated protein 1 LC3 antibody purchased from MBL (Woburn, MA). Bound antibody was detected using the enhanced Pierce Daco/Pico detection kit (Thermo).
Transmission electron microscope and immunochemical analysis Cells were grown on six-well culture dishes for each time point. They were then washed with PBS to remove unbound protein and fixed with 2% paraformaldehyde and 3% glutaraldehyde in 1% sodium cacodylate buffer, pH 7.3, for 1 h at room temperature. Other cells were fixed and stained for IFN protein as described earlier. 1 Samples were then infiltrated, embedded in Spurr's lowviscosity medium, and allowed to polymerize in a 60 1C oven for 2 days. Glass coverslips were removed by dipping the blocks in liquid nitrogen. Ultra thin sections were cut with an LKB Ultracut microtome (Leica, Deerfield, IL), stained with uranyl acetate and lead citrate in an LKB Ultrastainer, and examined in a JEM-1010 transmission electron microscope at an acceleration voltage of 80 kV. Digital images were obtained using an AMT Imaging System (Advanced Microscopy Techniques Corp., Danvers, MA).
Generation of CM and CM treatment
The UC9 and KU7 bladder cancer and TERT-NHUC cells were plated into 100-mm dishes at 1 Â 10 6 cells per dish. After Ad-IFNa infection as outlined above, the medium was harvested from the Ad-IFNa-infected dishes at various times after treatment, filtered through a 0.22-mm filter and were then termed either UC9 CM-Ad-IFN or KU7 CM-Ad-IFN. The medium harvested from the non-infected control cells were termed UC9 CM-control. All of the conditioned media were then aliquoted and stored at À80 1C. CM was used in treatment of normal or tumor cells by adding 1 part CM to 4 part growth medium for a final 1:5 dilution.
Cell-cycle analysis
The tumor cells and normal urothelial cells were plated into 100-mm dishes at 1 Â 10 6 cells per dish or into 60-mm dishes at 1 Â 10 5 before infection. After Ad-IFN infection, the cells were cultured with or without the autophagy inhibitor 3-MA, the control and treated cells were harvested with trypsin-EDTA and washed in 1 ml of cold PBS. The cells were suspended in 1.0 ml of propidium iodide solution (50 mg ml À1 propidium iodide, 0.1% Triton X-100 and 0.1% sodium citrate in PBS). Cells were then incubated at 4 1C for 2 h in the dark, and then the fluorescence was read on a FACSCanto II cytometer (BD, Brea, CA). The results were analyzed with Diva (BD) and FlowJo (Ishland, OR).
Quantification of acidic organelles
Autophagy was measured by the development of acidic vesicular organelle staining with LysoTracker Red DND-99 (Invitrogen, Carlsbad, CA). The tumor cells and normal urothelial cells were plated into 100-mm dishes at 1-2 Â 10 6 cells per dish and infected with Ad-IFNa. Before harvesting, the medium was removed and re-fed with medium containing 75 ng ml À1 of LysoTracker Red DND-99, and incubated at 37 1C 5% CO 2 for 15 min. Finally, the control and treated cells were harvested with trypsin-EDTA and washed in 1 ml of cold PBS. The stained cells were analyzed by flow cytometry using the FACSCanto II cytometer (BD).
Statistical analysis
Sub-G1 results were expressed as the mean±standard error of the mean. Each treatment was assayed three times, and the analysis was performed using the Descriptive Statistics Module of the Statistica software (StatSoft, Inc., Tulsa, OK). Flow cytometry results were analyzed with the Diva and FlowJo software.
Results and discussion
Direct Ad-IFNa infection induces different stages of autophagy in IFN resistant bladder tumor cells and normal urothelial cells as analyzed by electron microscopy, whereas Ad-IFNa produced bystander factors do not Ad-IFNa produces marked cytotoxicity to cancer cells, which are resistant to the IFN protein itself. 1 An example is shown in Figure 1b An example of this cytotoxicity is shown in Figure 1c . As this type of cancer cell death is produced by bystander factors and not from Ad-IFNa transfection and expression, no cells show IFN intracellular staining such as seen in Figure 1b . In contrast, Ad-IFNa produces no cytotoxicity in normal urothelial cells (Figure 1f ), although these cells are readily transfected with Ad-IFNa and show similar IFN perinuclear staining as seen after transfection of cancer cells (Figure 1f, insert) . Ad-b-gal also showed no cytotoxicity when used as an adenoviralmediated control (Figure 1d) .
When the cancer cells were examined by electron microscopy (EM) after Ad-IFNa treatment, early autophagy was observed as indicated by the presence of numerous autophagosomes (Figure 2b ). In contrast, little evidence for Ad-IFNa-induced late stage autophagy or the presence of autophagolysosome was seen (Figure 2b ). In addition, no significant evidence of autophagy was found when CM produced from Ad-IFNa-treated IFN resistant UC9 cancer cells was incubated with UC9 cells (Figure 2c ) although marked cytotoxicity was observed (Figure 1c) . This provided the first evidence that little or no autophagy occurs during bystander-produced cell kill. In contrast, Ad-IFNa-treated normal urothelial cells contained mostly later stage autophagic changes, namely autophagolysosomes (Figure 2f ). Ad-b-gal-treated cancer cells (Figure 2d ) as well as normal cells contained little evidence of autophagy at the EM level.
Autophagic changes occur in acidic vesicular organelles after treatment with Ad-IFNa but not by bystander products The burden of an increased autophagic influx will tend to stimulate lysosomal proton pumping, thus establishing a correlation between autophagic activity and overall lysosomal acidity. Weakly basic amines selectively accumulate in cellular compartments with low internal pH and can be used to investigate the biosynthesis and pathogenesis of lysosomes. Among a number of fluorescent acidotropic dyes, which are available for staining of lysosomes on the basis of acidity, LysoTracker Red DND-99 is often used. These dyes are able to cross the lysosomal membrane as uncharged molecules, but become protonated and trapped in the acidic interior of the lysosome. The intensity of lysosomal staining, detected by fluorescence microscopy or flow cytometry is roughly proportional to lysosomal acidity. As the general increase in lysosomal acidity accompanying increased autophagy will increase the intensity of fluorescent dye, quantification can be performed by counting the number of detectable lysosomes per cell as well as by measuring the overall fluorescence intensity. The ability to induce autophagy in both normal and KU7 cancer cells after Ad-IFNa could therefore readily be shown by measuring Lysotracker DND intensity (Figures 3a and b , respectively), whereas no change was seen when CM from Ad-IFNa-treated KU7 cancer cells was incubated with the KU7 cells (Figure 3c ). is cleaved in the carboxyl terminal region, generating a soluble form, LC3-I, which is later modified to a membrane-bound form, LC3-II. LC3-II is localized to pre-autophagosomes and autophagosomes, making it an autophagosomal marker. After the fusion of the autophagosome with the lysosome, intra-autophagosomal LC3-II is degraded by lysosomal hydrolytic enzymes. Both the LC3-I and LC3-II are detected as two bands after SDS-PAGE and immunoblotting. 5 After Ad-IFNa infection, LC3-II conversion was observed in the UC9 cancer cells but was not seen in the normal NHU cells, although an increase in LC3-I was found in the normal cells after Ad-IFNa treatment (Figure 4 ). In addition, the LC3-II increase could be blocked in the UC9 cancer cells by the addition of the autophagy inhibitor, 3-MA (Figure 4) . A possible reason for lack of LC3-II in Ad-IFNa-infected normal cells is that LC3-II itself could have been completely degraded and recycled during late autophagy within the autophagolysosomes, which are the primary components in normal cells, whereas autophagy is not allowed to go to completion in the cancer cells, where primarily autophagosomes are observed. This possibility is consistent with the EM observations (Figure 2 ). In our view, the high level of LC3-II in Ad-IFNa-infected cancer cells not only reflects that autophagy has been induced, but that the process of autophagy is not allowed to continue to completion unlike that seen in normal NHU cells. The autophagy inhibitor 3-MA produces increased apoptosis in cancer cells measuring by the sub-G1 fraction We have proven that Ad-IFNa induces apoptosis in IFN resistant cancer cells as measured by an increase in the sub-G1 population in cancer cells. [1] [2] [3] We now find that the addition of the autophagy inhibitor, 3-MA, increases the sub-G1 population in both UC9 and KU7 ( Figure 5 ). This result suggests that autophagy also has a protective effect in those cancer cells which are transfected with Ad-IFNa and express IFNa (Figure 1b, insert) . However, as mentioned above, this autophagic process does not proceed to completion in the cancer cells, and marked cytotoxicity is produced. In contrast, Ad-IFNa-induced autophagy in normal cells provides a more protective effect with little cytotoxicity being seen.
A Phase 1 study using intravesical treatment of Ad-IFNa for recurrent BCG refractory superficial bladder cancer is nearing completion and the initial results have been presented. 6 Almost 50% of the patients treated obtained a complete remission. Except for initial urinary urgency, which could be controlled with prior anti-cholinergic medication, no other side effects on the bladder were observed. High urine IFNa levels were obtained in this study, indicating that significant Ad-IFNa transfection and expression had occurred in the normal urothelium as well as a portion of the cancer cells present. The lack of apparent toxicity of Ad-IFNa to the patient's urothelium may have reflected, in part, the completion of the autophagic process we have reported here in normal urothelial cells. By analogy, the incomplete autophagic process in cancer cells may be responsible for the insufficient protection of cancer cells from cell death after the direct transfection and expression of Ad-IFNa. Moreover, the bystander effects after Ad-IFNa treatment that cause cell death in cancer cells 3, 4 are apparently devoid of any autophagic protection. This latter mechanism of Ad-IFNa-produced cancer cell kill is particularly potent, especially in cancer cells that are resistant to the cytotoxic effects of the IFNa protein itself. 
